Integral Health Asset Management, LLC Argenx Se Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $11.1 Million - $16.5 Million	30,000 Added 75.0%	70,000 $34.4 Million
Q2 2023 Aug 11, 2023	BUY	$360.14 - $422.58 $10.1 Million - $11.8 Million	28,000 Added 233.33%	40,000 $15.6 Million
Q1 2023 May 09, 2023	BUY	$334.23 - $403.65 $668,460 - $807,300	2,000 Added 20.0%	12,000 $4.47 Million
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $3.42 Million - $4.02 Million	10,000 New	10,000 $3.79 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.